Laboratory testing for endometriosis

Clinica Chimica Acta

Volumn 340, Issue 1-2, 2004, Pages 41-56

  Bedaiwy, Mohamed A ^a   Falcone, Tommaso ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Endometriosis; Peritoneal fluid markers; Serum markers

Indexed keywords

AROMATASE; AUTOANTIBODY; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CYTOKERATIN; GAMMA INTERFERON; HORMONE RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; PLACENTA PROTEIN 14; RANTES; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; CELLULAR IMMUNITY; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOME ANALYSIS; HUMAN; LABORATORY TEST; MACROPHAGE; MEDLINE; NATURAL KILLER CELL; PERITONEAL FLUID LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY; TH1 CELL; TH2 CELL;

EID: 0842281438     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.10.021     Document Type: Review

References (135)

1. Revised American Fertility Society classification of endometriosis. Fertil. Steril. 43:1985;351-352.
2. Meden H., Fattahi-Meibodi A. CA 125 in benign gynecological conditions. Int. J. Biol. Markers. 13:1998;231-237.
3. Pittaway D.E., Fayez J.A. Serum CA-125 antigen levels increase during menses. Am. J. Obstet. Gynecol. 156:1987;75-76.
4. Eltabbakh G.H., Belinson J.L., Kennedy A.W., Gupta M., Webster K., Blumenson L.E. Serum CA-125 measurements >65 U/mL. Clinical value. J. Reprod. Med. 42:1997;617-624.
5. Malkasian G.D. Jr., Knapp R.C., Lavin P.T., Zurawski V.R. Jr., Podratz K.C., Stanhope C.R.et al. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am. J. Obstet. Gynecol. 159:1988;341-346.
6. Pittaway D.E., Fayez J.A. The use of CA-125 in the diagnosis and management of endometriosis. Fertil. Steril. 46:1986;790-795.
7. Moretuzzo R.W., DiLauro S., Jenison E., Chen S.L., Reindollar R.H., McDonough P.G. Serum and peritoneal lavage fluid CA-125 levels in endometriosis. Fertil. Steril. 50:1988;430-433.
8. Barbati A., Cosmi E.V., Spaziani R., Ventura R., Montanino G. Serum and peritoneal fluid CA-125 levels in patients with endometriosis. Fertil. Steril. 61:1994;438-442.
9. Mol B.W., Bayram N., Lijmer J.G., Wiegerinck M.A., Bongers M.Y., van der Veen F.et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil. Steril. 70:1998;1101-1108.
10. Pittaway D.E., Rondinone D., Miller K.A., Barnes K. Clinical evaluation of CA-125 concentrations as a prognostic factor for pregnancy in infertile women with surgically treated endometriosis. Fertil. Steril. 64:1995;321-324.
11. Fedele L., Arcaini L., Vercellini P., Bianchi S., Candiani G.B. Serum CA 125 measurements in the diagnosis of endometriosis recurrence. Obstet. Gynecol. 72:1988;19-22.
12. Koprowski H., Steplewski Z., Mitchell K., Herlyn M., Herlyn D., Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somat. Cell Genet. 5:1979;957-971.
13. Ye C., Ito K., Komatsu Y., Takagi H. Extremely high levels of CA19-9 and CA125 antigen in benign mucinous ovarian cystadenoma. Gynecol. Oncol. 52:1994;267-271.
14. Imai A., Horibe S., Takagi A., Takagi H., Tamaya T. Drastic elevation of serum CA125, CA72-4 and CA19-9 levels during menses in a patient with probable endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 78:1998;79-81.
15. Matalliotakis I., Panidis D., Vlassis G., Neonaki M., Goumenou A., Koumantakis E. Unexpected increase of the CA 19-9 tumour marker in patients with endometriosis. Eur. J. Gynaecol. Oncol. 19:1998;498-500.
16. Harada T., Kubota T., Aso T. Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis. Fertil. Steril. 78:2002;733-739.
17. Vigano P., Somigliana E., Gaffuri B., Santorsola R., Busacca M., Vignali M. Endometrial release of soluble intercellular adhesion molecule 1 and endometriosis: relationship to the extent of the disease. Obstet. Gynecol. 95:2000;115-118.
18. De Placido G., Alviggi C., Di Palma G., Carravetta C., Matarese G., Landino G.et al. Serum concentrations of soluble human leukocyte class I antigens and of the soluble intercellular adhesion molecule-1 in endometriosis: relationship with stage and non-pigmented peritoneal lesions. Hum. Reprod. 13:1998;3206-3210.
19. Wu M.H., Yang B.C., Hsu C.C., Lee Y.C., Huang K.E. The expression of soluble intercellular adhesion molecule-1 in endometriosis. Fertil. Steril. 70:1998;1139-1142.
20. Daniel Y., Geva E., Amit A., Eshed-Englender T., Baram A., Fait G.et al. Do soluble cell adhesion molecules play a role in endometriosis? Am. J. Reprod. Immunol. 43:2000;160-166.
21. Matalliotakis I.M., Vassiliadis S., Goumenou A.G., Athanassakis I., Koumantakis G.E., Neonaki M.A.et al. Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment. J. Reprod. Immunol. 51:2001;9-19.
22. Somigliana E., Vigano P., Candiani M., Felicetta I., Di Blasio A.M., Vignali M. Use of serum-soluble intercellular adhesion molecule-1 as a new marker of endometriosis. Fertil. Steril. 77:2002;1028-1031.
23. Mueller M.D., Vigne J.L., Vaisse C., Taylor R.N. Glycodelin: a pane in the implantation window. Semin. Reprod. Med. 18:2000;289-298.
24. Telimaa S., Kauppila A., Ronnberg L., Suikkari A.M., Seppala M. Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis. Suppression by treatment with danazol and high-dose medroxyprogesterone acetate. Am. J. Obstet. Gynecol. 161:1989;866-871.
25. Joshi S.G. Progestin-dependent human endometrial protein: a marker for monitoring human endometrial function. Adv. Exp. Med. Biol. 230:1987;167-186.
26. Maathuis J.B., Van Look P.F., Michie E.A. Changes in volume, total protein and ovarian steroid concentrations of peritoneal fluid throughout the human menstrual cycle. J. Endocrinol. 76:1978;123-133.
27. Syrop C.H., Halme J. Peritoneal fluid environment and infertility. Fertil. Steril. 48:1987;1-9.
28. Syrop C.H., Halme J. Cyclic changes of peritoneal fluid parameters in normal and infertile patients. Obstet. Gynecol. 69:1987;416-418.
29. Fedele L., Vercellini P., Arcaini L., da Dalt M.G., Candiani G.B. CA 125 in serum, peritoneal fluid, active lesions, and endometrium of patients with endometriosis. Am. J. Obstet. Gynecol. 158:1988;166-170.
30. Fisk N.M., Tan C.E. CA 125 in peritoneal fluid and serum of patients with endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 29:1988;153-158.
31. Gurgan T., Kisnisci H., Yarali H., Aksu T., Zeyneloglu H., Develioglu O. Serum and peritoneal fluid CA-125 levels in early stage endometriosis. Gynecol. Obstet. Invest. 30:1990;105-108.
32. Kruitwagen R.F., Thomas C., Poels L.G., Koster A.M., Willemsen W.N., Rolland R. High CA-125 concentrations in peritoneal fluid of normal cyclic women with various infertility-related factors as demonstrated with two-step immunoradiometric assay. Fertil. Steril. 56:1991;863-869.
33. Takahashi K., Nagata H., Musa A.A., Shibukawa T., Yamasaki H., Kitao M. Clinical usefulness of CA-125 levels in the menstrual discharge in patients with endometriosis. Fertil. Steril. 54:1990;360-362.
34. Abae M., Gibson M., Chapitis J., Riddick D.H., Brumsted J.R. CA-125 levels in human uterine fluid. Fertil. Steril. 57:1992;531-534.
35. Lebovic D.I., Mueller M.D., Taylor R.N. Immunobiology of endometriosis. Fertil. Steril. 75:2001;1-10.
36. Nothnick W.B. Treating endometriosis as an autoimmune disease. Fertil. Steril. 76:2001;223-231.
37. Steele R.W., Dmowski W.P., Marmer D.J. Immunologic aspects of human endometriosis. Am. J. Reprod. Immunol. 6:1984;33-36.
38. Badawy S.Z., Cuenca V., Stitzel A., Tice D. Immune rosettes of T and B lymphocytes in infertile women with endometriosis. J. Reprod. Med. 32:1987;194-197.
39. Dmowski W.P., Gebel H.M., Braun D.P. The role of cell-mediated immunity in pathogenesis of endometriosis. Acta Obstet. Gynecol. Scand. Suppl. 159:1994;7-14.
40. Witz C.A., Montoya I.A., Dey T.D., Schenken R.S. Characterization of lymphocyte subpopulations and T cell activation in endometriosis. Am. J. Reprod. Immunol. 32:1994;173-179.
41. Wilson T.J., Hertzog P.J., Angus D., Munnery L., Wood E.C., Kola I. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil. Steril. 62:1994;1086-1088.
42. Ho H.N., Chao K.H., Chen H.F., Wu M.Y., Yang Y.S., Lee T.Y. Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III-IV endometriosis. Hum. Reprod. 10:1995;2671-2675.
43. Kanzaki H., Wang H.S., Kariya M., Mori T. Suppression of natural killer cell activity by sera from patients with endometriosis. Am. J. Obstet. Gynecol. 167:1992;257-261.
44. Weed J.C., Arquembourg P.C. Endometriosis: can it produce an autoimmune response resulting in infertility? Clin. Obstet. Gynecol. 23:1980;885-893.
45. Mathur S., Peress M.R., Williamson H.O., Youmans C.D., Maney S.A., Garvin A.J.et al. Autoimmunity to endometrium and ovary in endometriosis. Clin. Exp. Immunol. 50:1982;259-266.
46. Gleicher N., Adelsberg B.R., Liu T.L., Cederqvist L.L., Phillips R.N., Siegel I. Immune complexes in pregnancy: III. Immune complexes in immune complex-associated conditions. Am. J. Obstet. Gynecol. 142:1982;1011-1015.
47. Meek S.C., Hodge D.D., Musich J.R. Autoimmunity in infertile patients with endometriosis. Am. J. Obstet. Gynecol. 158:1988;1365-1373.
48. Taylor P.V., Maloney M.D., Campbell J.M., Skerrow S.M., Nip M.M., Parmar R.et al. Autoreactivity in women with endometriosis. Br. J. Obstet. Gynaecol. 98:1991;680-684.
49. Evers J.L., Dunselman G.A., Van der Linden P.J. Markers for endometriosis. Baillieres Clin. Obstet. Gynaecol. 7:1993;715-739.
50. Wild R.A., Shivers C.A. Antiendometrial antibodies in patients with endometriosis. Am. J. Reprod. Immunol. Microbiol. 8:1985;84-86.
51. Hsu C.C., Yang B.C., Wu M.H., Huang K.E. Enhanced interleukin-4 expression in patients with endometriosis. Fertil. Steril. 67:1997;1059-1064.
52. Tsudo T., Harada T., Iwabe T., Tanikawa M., Nagano Y., Ito M.et al. Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues. Fertil. Steril. 73:2000;205-211.
53. Halme J., Becker S., Wing R. Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis. Am. J. Obstet. Gynecol. 148:1984;85-90.
54. Bedaiwy M.A., Falcone T., Sharma R.K., Goldberg J.M., Attaran M., Nelson D.R.et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum. Reprod. 17:2002;426-431.
55. Van Langendonckt A., Casanas-Roux F., Donnez J. Iron overload in the peritoneal cavity of women with pelvic endometriosis. Fertil. Steril. 78:2002;712-718.
56. Philippeaux M.M., Piguet P.F. Expression of tumor necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle. Am. J. Pathol. 143:1993;480-486.
57. Hunt J.S., Chen H.L., Hu X.L., Tabibzadeh S. Tumor necrosis factor-alpha messenger ribonucleic acid and protein in human endometrium. Biol. Reprod. 47:1992;141-147.
58. Eisermann J., Gast M.J., Pineda J., Odem R.R., Collins J.L. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil. Steril. 50:1988;573-579.
59. Keenan J.A., Chen T.T., Chadwell N.L., Torry D.S., Caudle M.R. IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am. J. Reprod. Immunol. 34:1995;381-385.
60. Braun D.P., Gebel H., House R., Rana N., Dmowski N.P. Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis. Fertil. Steril. 65:1996;1125-1129.
61. Braun D.P., Ding J., Dmowski W.P. Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis. Fertil. Steril. 78:2002;727-732.
62. Laird S.M., Li T.C., Bolton A.E. The production of placental protein 14 and interleukin 6 by human endometrial cells in culture. Hum. Reprod. 8:1993;793-798.
63. Rier S.E., Parsons A.K., Becker J.L. Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis. Fertil. Steril. 61:1994;294-299.
64. Tseng J.F., Ryan I.P., Milam T.D., Murai J.T., Schriock E.D., Landers D.V.et al. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J. Clin. Endocrinol. Metab. 81:1996;1118-1122.
65. Koyama N., Matsuura K., Okamura H. Cytokines in the peritoneal fluid of patients with endometriosis. Int. J. Gynaecol. Obstet. 43:1993;45-50.
66. Harada T., Yoshioka H., Yoshida S., Iwabe T., Onohara Y., Tanikawa M.et al. Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis. Am. J. Obstet. Gynecol. 176:1997;593-597.
67. Keenan J.A., Chen T.T., Chadwell N.L., Torry D.S., Caudle M.R. Interferon-gamma (IFN-gamma) and interleukin-6 (IL-6) in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am. J. Reprod. Immunol. 32:1994;180-183.
68. Taylor R.N., Ryan I.P., Moore E.S., Hornung D., Shifren J.L., Tseng J.F. Angiogenesis and macrophage activation in endometriosis. Ann. N. Y. Acad. Sci. 828:1997;194-207.
69. Lebovic D.I., Mueller M.D., Taylor R.N. Vascular endothelial growth factor in reproductive biology. Curr. Opin. Obstet. Gynecol. 11:1999;255-260.
70. D'Angelo G., Struman I., Martial J., Weiner R.I. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc. Natl. Acad. Sci. U. S. A. 92:1995;6374-6378.
71. Dvorak H.N., Senger D.R., Dvorak A.M., Harvey V.S., McDonagh J. Regulation of extravascular coagulation by microvascular permeability. Science. 227:1985;1059-1061.
72. Hornung D., Lebovic D.I., Shifren J.L., Vigne J.L., Taylor R.N. Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells. Fertil. Steril. 69:1998;909-915.
73. Shifren J.L., Tseng J.F., Zaloudek C.J., Ryan I.P., Meng Y.G., Ferrara N.et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab. 81:1996;3112-3118.
74. Donnez J., Smoes P., Gillerot S., Casanas-Roux F., Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum. Reprod. 13:1998;1686-1690.
75. McLaren J., Prentice A., Charnock-Jones D.S., Smith S.K. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum. Reprod. 11:1996;220-223.
76. Ortiz B.D., Krensky A.M., Nelson P.J. Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol. Cell Biol. 16:1996;202-210.
77. Hornung D., Ryan I.P., Chao V.A., Vigne J.L., Schriock E.D., Taylor R.N. Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J. Clin. Endocrinol. Metab. 82:1997;1621-1628.
78. Khorram O., Taylor R.N., Ryan I.P., Schall T.J., Landers D.V. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am. J. Obstet. Gynecol. 169:1993;1545-1549.
79. Simon C., Frances A., Piquette G.N., el Danasouri I., Zurawski G., Dang W.et al. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology. 134:1994;521-528.
80. Fakih H., Baggett B., Holtz G., Tsang K.Y., Lee J.C., Williamson H.O. Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil. Steril. 47:1987;213-217.
81. Taketani Y., Kuo T.M., Mizuno M. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am. J. Obstet. Gynecol. 167:1992;265-270.
82. Iwabe T., Harada T., Tsudo T., Tanikawa M., Onohara Y., Terakawa N. Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis. Fertil. Steril. 69:1998;924-930.
83. Ho H.N., Wu M.Y., Chao K.H., Chen C.D., Chen S.U., Yang Y.S. Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis. Hum. Reprod. 12:1997;2528-2533.
84. Mazzeo D., Vigano P., Di Blasio A.M., Sinigaglia F., Vignali M., Panina-Bordignon P. Interleukin-12 and its free p40 subunit regulate immune recognition of endometrial cells: potential role in endometriosis. J. Clin. Endocrinol. Metab. 83:1998;911-916.
85. McLaren J., Dealtry G., Prentice A., Charnock-Jones D.S., Smith S.K. Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis. Hum. Reprod. 12:1997;1307-1310.
86. Arici A., Oral E., Attar E., Tazuke S.I., Olive D.L. Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells. Fertil. Steril. 67:1997;1065-1072.
87. Fukaya T., Sugawara J., Yoshida H., Yajima A. The role of macrophage colony stimulating factor in the peritoneal fluid in infertile patients with endometriosis. Tohoku J. Exp. Med. 172:1994;221-226.
88. Oosterlynck D.J., Meuleman C., Waer M., Koninckx P.R. Transforming growth factor-beta activity is increased in peritoneal fluid from women with endometriosis. Obstet. Gynecol. 83:1994;287-292.
89. Hammond M.G., Oh S.T., Anners J., Surrey E.S., Halme J. The effect of growth factors on the proliferation of human endometrial stromal cells in culture. Am. J. Obstet. Gynecol. 168:1993;1131-1136. [discussion 1136-8].
90. Iwabe T., Harada T., Tsudo T., Nagano Y., Yoshida S., Tanikawa M.et al. Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression. J. Clin. Endocrinol. Metab. 85:2000;824-829.
91. Zhang R.J., Wild R.A., Ojago J.M. Effect of tumor necrosis factor-alpha on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system. Fertil. Steril. 59:1993;1196-1201.
92. Osteen K.G., Keller N.R., Feltus F.A., Melner M.H. Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium. Gynecol. Obstet. Invest. 48:1999;2-13.
93. Badawy S.Z., Cuenca V., Stitzel A., Jacobs R.D., Tomar R.H. Autoimmune phenomena in infertile patients with endometriosis. Obstet. Gynecol. 63:1984;271-275.
94. Murphy A.A., Palinski W., Rankin S., Morales A.J., Parthasarathy S. Evidence for oxidatively modified lipid-protein complexes in endometrium and endometriosis. Fertil. Steril. 69:1998;1092-1094.
95. Dunselman G.A., Bouckaert P.X., Evers J.L. The acute-phase response in endometriosis of women. J. Reprod. Fertil. 83:1988;803-808.
96. Wild R.A., Shivers C.A., Medders D. Detection of antiendometrial antibodies in patients with endometriosis: methodological issues. Fertil. Steril. 58:1992;518-521.
97. Wild R.A., Hirisave V., Podczaski E.S., Coulam C., Shivers C.A., Satyaswaroop P.G. Autoantibodies associated with endometriosis: can their detection predict presence of the disease? Obstet. Gynecol. 77:1991;927-931.
98. Kennedy S.H., Starkey P.M., Sargent I.L., Hicks B.R., Barlow D.H. Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin. Obstet. Gynecol. 75:1990;914-918.
99. Halme J., Mathur S. Local autoimmunity in mild endometriosis. Int. J. Fertil. 32:1987;309-311.
100. Wang Y., Sharma R.K., Falcone T., Goldberg J., Agarwal A. Importance of reactive oxygen species in the peritoneal fluid of women with endometriosis or idiopathic infertility. Fertil. Steril. 68:1997;826-830.
101. Murphy A.A., Santanam N., Morales A.J., Parthasarathy S. Lysophosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes is elevated in endometriosis. J. Clin. Endocrinol. Metab. 83:1998;2110-2113.
102. Salonen J.T., Yla-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R.et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
103. Stefansson H., Geirsson R.T., Steinthorsdottir V., Jonsson H., Manolescu A., Kong A.et al. Genetic factors contribute to the risk of developing endometriosis. Hum. Reprod. 17:2002;555-559.
104. Taylor R.N., Lundeen S.G., Giudice L.C. Emerging role of genomics in endometriosis research. Fertil. Steril. 78:2002;694-698.
105. Vaisse C., Atger M., Potier B., Milgrom E. Human placental protein 14 gene: sequence and characterization of a short duplication. DNA Cell Biol. 9:1990;401-413.
106. Kao L.C., Tulac S., Lobo S., Imani B., Yang J.P., Germeyer A.et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology. 143:2002;2119-2138.
107. Yan S.F., Fujita T., Lu J., Okada K., Shan Zou Y., Mackman N.et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat. Med. 6:2000;1355-1361.
108. Yan S.F., Pinsky D.J., Mackman N., Stern D.M. Egr-1: is it always immediate and early? J. Clin. Invest. 105:2000;553-554.
109. Vidal F., Aragones J., Alfranca A., de Landazuri M.O. Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1. Blood. 95:2000;3387-3395.
110. Eyster K.M., Boles A.L., Brannian J.D., Hansen K.A. DNA microarray analysis of gene expression markers of endometriosis. Fertil. Steril. 77:2002;38-42.
111. Kitawaki J., Noguchi T., Amatsu T., Maeda K., Tsukamoto K., Yamamoto T. et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol. Reprod. 57:1997;514-519.
112. Dheenadayalu K., Mak I., Gordts S., Campo R., Higham J., Puttemans P.et al. Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosis. Fertil. Steril. 78:2002;825-829.
113. Takayama K., Zeitoun K., Gunby R.T., Sasano H., Carr B.R., Bulun S.E. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil. Steril. 69:1998;709-713.
114. Bulun S.E., Zeitoun K., Takayama K., Noble L., Michael D., Simpson E.et al. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr. Relat. Cancer. 6:1999;293-301.
115. Zeitoun K.M., Bulun S.E. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil. Steril. 72:1999;961-969.
116. Bulun S.E., Zeitoun K.M., Takayama K., Simpson E., Sasano H. Aromatase as a therapeutic target in endometriosis. Trends Endocrinol. Metab. 11:2000;22-27.
117. Bouquet de Joliniere J., Validire P., Canis M., Doussau M., Levardon M., Gogusev J. Human endometriosis-derived permanent cell line (FbEM-1): establishment and characterization. Hum. Reprod. Update. 3:1997;117-123.
118. Mai K.T., Yazdi H.M., Perkins D.G., Parks W. Pathogenetic role of the stromal cells in endometriosis and adenomyosis. Histopathology. 30:1997;430-442.
119. Matthews C.J., Redfern C.P., Hirst B.H., Thomas E.J. Characterization of human purified epithelial and stromal cells from endometrium and endometriosis in tissue culture. Fertil. Steril. 57:1992;990-997.
120. Nisolle M., Casanas-Roux F., Donnez J. Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil. Steril. 68:1997;912-919.
121. Dmowski W.P., Gebel H., Braun D.P. Decreased apoptosis and sensitivity to macrophage mediated cytolysis of endometrial cells in endometriosis. Hum. Reprod. Update. 4:1998;696-701.
122. Jiang J., Wu R., Wang Z., Sun H., Xu Z., Xiu H. Effect of mifepristone on estrogen and progesterone receptors in human endometrial and endometriotic cells in vitro. Fertil. Steril. 77:2002;995-1000.
123. Oehler M.K., Rees M.C., Bicknell R. Steroids and the endometrium. Curr. Med. Chem. 7:2000;543-560.
124. Marcoux S., Maheux R., Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. N. Engl. J. Med. 337:1997;217-222.
125. Patton P.E., Field C.S., Harms R.W., Coulam C.B. CA-125 levels in endometriosis. Fertil. Steril. 45:1986;770-773.
126. Molo M.W., Kelly M., Radwanska E., Binor Z. Preoperative serum CA-125 and CA-72 in predicting endometriosis in infertility patients. J. Reprod. Med. 39:1994;964-966.
127. Hornstein M.D., Harlow B.L., Thomas P.P., Check J.H. Use of a new CA 125 assay in the diagnosis of endometriosis. Hum. Reprod. 10:1995;932-934.
128. Moloney M.D., Thornton J.G., Cooper E.H. Serum CA 125 antigen levels and disease severity in patients with endometriosis. Obstet. Gynecol. 73:1989;767-769.
129. O'Shaughnessy A., Check J.H., Nowroozi K., Lurie D. CA 125 levels measured in different phases of the menstrual cycle in screening for endometriosis. Obstet. Gynecol. 81:1993;99-103.
130. Colacurci N., Fortunato N., De Franciscis P., Cardone A. Relevance of CA-125 in the evaluation of endometriosis. Clin. Exp. Obstet. Gynecol. 23:1996;150-154.
131. Muscatello R., Cucinelli F., Fulghesu A., Lanzone A., Caruso A., Mancuso S. Multiple serum marker assay in the diagnosis of endometriosis. Gynecol. Endocrinol. 6:1992;265-269.
132. Medl M., Ogris E., Peters-Engl C., Mierau M., Buxbaum P., Leodolter S. Serum levels of the tumour-associated trypsin inhibitor in patients with endometriosis. Br. J. Obstet. Gynaecol. 104:1997;78-81.
133. Ismail M.A., Rotmensch J., Mercer L.J., Block B.S., Salti G.I., Holt J.A. CA-125 in peritoneal fluid from patients with nonmalignant gynecologic disorders. J. Reprod. Med. 39:1994;510-512.
134. Lanzone A., Marana R., Muscatello R., Fulghesu A.M., Dell'Acqua S., Caruso A.et al. Serum CA-125 levels in the diagnosis and management of endometriosis. J. Reprod. Med. 36:1991;603-607.
135. Ozaksit G., Caglar T., Cicek N., Kuscu E., Batioglu S., Gokmen O. Serum CA 125 levels before, during and after treatment for endometriosis. Int. J. Gynaecol. Obstet. 50:1995;269-273.